+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biologics Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery

  • ID: 5232536
  • Report
  • December 2020
  • Region: Global
  • 391 pages
  • The Business Research Company

FEATURED COMPANIES

  • AbbVie Inc.
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
Biologics Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global biologics market.

Reasons to Purchase
  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
Description:

Where is the largest and fastest growing market for the biologics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global biologics market opportunities and strategies to 2030 report answers all these questions and many more.

The report covers the following chapters
  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, by distribution channel, by route of administration, by drug classification, and by mode of purchase.
  • Market Characteristics - The market characteristics section of the report defines and explains the biologics market. This chapter includes different products and services covered in the report and basic definitions.
Supply Chain - The supply chain section of the report defines and explains the key players in the biologics market supply chain.
Product Analysis - The product analysis section of the report describes the leading products/services in the market along with key features and differentiators for those products/services.
Customer Information- This chapters covers recent customers’ trends/preferences in the global biologics market.
  • Trends and Strategies - This chapter describes the major trends shaping the global biologics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 - This section describes the impact of COVID-19 on the biologics market.
  • Global Market Size and Growth - This section contains the global historic (2015-2019) and forecast (2023F, 2025F, 2030F) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
  • Regional Analysis - This section contains the historic (2015-2019), forecast (2019-2023F, 2025F, 2030F) market value and growth and market share comparison by region.
Market Segmentation - This section contains the market values (2015-2019, 2019-2023F, 2025F, 2030F) and analysis for segment by type in the market.
  • Regional Market Size and Growth - This section contains the region’s market size (2019), historic and forecast (2015-2019, and 2023F, 2025F, 2030F) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
  • Competitive Landscape - This section covers details on the competitive landscape of the global biologics market, estimated market shares and company profiles of the leading players.
  • Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities and Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions and Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for biologics companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered: The global biologics market is segmented by -
  • By Type: Therapeutic Proteins; Monoclonal Antibodies ((MAbS); Vaccines
  • Therapeutic Proteins are further segmented into - Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Other Therapeutic Proteins
  • Monoclonal Antibodies (MAbS) are further segmented into - Anti-Cancer MABS; Immunological MABS; Anti-Infective Monoclonal Antibodies (MABS); Neuropharmacological Mabs; Cardiovascular and Cerebrovascular MABS; Others - Monoclonal Antibodies (MABS)
Vaccines are further segmented into- Anti-Infective Vaccines; Autoimmunity Vaccines; Others-Vaccines
  • By Route Of Administration: Oral; Others (IV and IP)
  • By Drug Classification: Branded Drugs; Generic Drugs
  • By Mode Of Purchase: Prescription Drugs; Over-The-Counter (OTC) Drugs
  • By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; AbbVie Inc.; Merck & Co., Inc.; Johnson & Johnson

Countries: China, Australia, Hong Kong, India, Indonesia, Japan, Malaysia, New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam, Canada, Mexico, USA, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK, Czech Republic, Poland, Romania, Russia, Saudi Arabia, Israel, Turkey, UAE, Egypt, Nigeria, South Africa

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
1. Biologics Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation by Geography
6.2. Biologics Market Segmentation by Type
6.2.1. Monoclonal Antibodies (MAbS) Segmentation by Type
6.2.2. Therapeutic Proteins Segmentation by Type
6.2.3. Vaccines Segmentation by Type
6.3. Biologics Market Segmentation by Route of Administration
6.4. Biologics Market Segmentation by Mode of Purchase
6.5. Biologics Market Segmentation by Distribution Channel

7. Biologics Market Characteristics
7.1. Market Definition
7.2. Segmentation by Type
7.2.1. Therapeutic Proteins
7.2.2. Monoclonal Antibodies ((MAbS)
7.2.3. Vaccines
7.3. Market Segmentation by Route of Administration
7.3.1. Oral
7.3.2. Others (IV and IP)
7.4. Market Segmentation by Drug Classification
7.4.1. Branded Drugs
7.4.2. Generic Drugs
7.5. Market Segmentation by Mode of Purchase
7.5.1. Prescription Drugs
7.5.2. Over-The-Counter (OTC) Drugs
7.6. Market Segmentation by Distribution Channel
7.6.1. Hospital Pharmacies
7.6.2. Retail Pharmacies
7.6.3. Online Pharmacies

8. Biologics Market, Supply Chain Analysis
8.1. Raw Material Suppliers
8.2. Research and Development
8.2.1. Clinical Studies
8.2.2. Contract Research Organization (CRO)
8.2.3. Approval
8.3. Biologics Manufacturing
8.3.1. Contract Manufacturing Organization (CMO)
8.4. Distribution
8.4.1. Wholesalers/Distributors
8.4.2. Retailers
8.4.3. End Users

9. Biologics Market Product Analysis - Product Examples

10. Biologics Market Customer Information
10.1. Awareness of The Patients For Biosimilars and Biologics
10.2. Perception On The Adoption of Biosimilars
10.3. Patients’ Preference For Biosimilar Over Biologics
10.4. Preference For Influenza Vaccines With Fewer Side Effects
10.5. Hesitance of Patients Towards Immunization Vaccines Due To Its Side Effects

11. Biologics Market Trends and Strategies
11.1. Revised FDA Regulations To Facilitate Biologics Drug Development
11.2. Higher Profit Margins For Biologics
11.3. Shift From Small Molecules To Biologics
11.4. Robust Research & Development
11.5. Demand For Biologics in The Treatment of Complex Diseases

12. Impact of COVID-19 On Biologics Market
12.1. Impact On R&D Funding
12.2. Impact On Supply Chain
12.3. Recovery

13. Global Biologics Market Size and Growth
13.1. Market Size
13.2. Historic Market Growth, 2015-2019, Value ($ Million)
13.2.1. Drivers of The Market 2015-2019
13.2.2. Restraints On The Market 2015-19
13.3. Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
13.3.1. Drivers of The Market 2019-2023
13.3.2. Restraints On The Market 2019-2023

14. Biologics Market, Regional Analysis
14.1. Global Biologics Market, by Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
14.2. Global Biologics Market, 2015-2023, Historic and Forecast, by Region
14.3. Global Biologics Market, 2019-2023, Growth and Market Share Comparison, by Region

15. Global Biologics Market Segmentation
15.1. Global Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.1.1. Monoclonal Antibodies
15.1.2. Therapeutic Proteins
15.1.3. Vaccines
15.1.4. Global Monoclonal Antibodies (MAbS) Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.1.5. Anti-Cancer MAbS
15.1.6. Immunological MAbS
15.1.7. Anti-Infective Monoclonal Antibodies (MAbS)
15.1.8. Cardiovascular and Cerebrovascular MAbS
15.1.9. Neuropharmacological MABS
15.1.10. Others - Monoclonal Antibodies (MAbs)
15.1.11. Global Therapeutic Proteins Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.1.12. Metabolic Disorders Therapeutic Proteins
15.1.13. Cancer Therapeutic Proteins
15.1.14. Cardiovascular Therapeutic Proteins
15.1.15. Immunological Therapeutic Proteins
15.1.16. Others - Therapeutic Proteins
15.1.17. Global Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.1.18. Anti-Infective Vaccines
15.1.19. Autoimmunity Vaccines
15.1.20. Others-Vaccines
15.2. Global Biologics Market, Segmentation by Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.2.1. Oral
15.2.2. Others
15.3. Global Biologics Market, Segmentation by Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.3.1. Branded Drugs
15.3.2. Generic Drugs
15.4. Global Biologics Market, Segmentation by Mode of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.4.1. Prescription Drugs
15.4.2. OTC Drugs
15.5. Global Biologics Market, Segmentation by Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Online Pharmacies

16. Global Biologics Market Comparison with Macro Economic Factors
16.1. Biologics Market Size, Percentage of GDP, Global
16.2. Per Capita Average Biologics Market Expenditure, Global

17. Asia-Pacific Biologics Market
17.1. Asia-Pacific Biologics Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. Impact of COVID-19
17.1.4. Background Information
17.1.5. Government Initiatives
17.1.6. Regulations
17.1.7. Regulatory Bodies
17.1.8. Major Associations
17.1.9. Taxes Levied
17.1.10. Corporate Tax Structure
17.1.11. Investments
17.1.12. Major Companies
17.2. Asia-Pacific Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.3. Asia-Pacific Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
17.4. Asia-Pacific Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.5. Asia-Pacific Biologics Market, 2019, by Country, Value ($ Million)
17.6. Asia-Pacific Biologics Market, 2015-2023, Historic and Forecast, by Country
17.7. Asia-Pacific Biologics Market, 2019-2023, Growth and Market Share Comparison, by Country
17.8. Asia-Pacific Biologics Market Metrics
17.8.1. Per Capita Biologics Expenditure, 2019, Asia-Pacific Major Countries
17.8.2. Estimated Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Asia-Pacific Countries
17.8.3. Estimated Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Asia-Pacific Countries
17.9. Asia-Pacific Biologics Market: Country Analysis
17.10. Australia Biologics Market
17.11. Australia Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.12. Australia Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
17.13. Australia Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.14. China Biologics Market
17.15. China Biologics Market Overview
17.15.1. Country Information
17.15.2. Market Information
17.15.3. Impact of COVID-19
17.15.4. Background Information
17.15.5. Government Initiatives
17.15.6. Regulations
17.15.7. Regulatory Bodies
17.15.8. Major Associations
17.15.9. Taxes Levied
17.15.10. Corporate Tax Structure
17.15.11. Investments
17.15.12. Major Companies
17.16. China Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.17. China Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
17.18. China Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.19. Hong Kong Biologics Market
17.20. Hong Kong Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.21. Hong Kong Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
17.22. India Biologics Market
17.23. India Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.24. India Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
17.25. India Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.26. Indonesia Biologics Market
17.27. Indonesia Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.28. Indonesia Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
17.29. Indonesia Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.30. Japan Biologics Market
17.31. Japan Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.32. Japan Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
17.33. Japan Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.34. Malaysia Biologics Market
17.35. Malaysia Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.36. Malaysia Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
17.37. New Zealand Biologics Market
17.38. New Zealand Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.39. New Zealand Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
17.40. Philippines Biologics Market
17.41. Philippines Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.42. Philippines Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
17.43. Singapore Biologics Market
17.44. Singapore Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.45. Singapore Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
17.46. South Korea Biologics Market
17.47. South Korea Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.48. South Korea Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
17.49. South Korea Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.50. Thailand Biologics Market
17.51. Thailand Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.52. Thailand Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
17.53. Vietnam Biologics Market
17.54. Vietnam Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
17.55. Vietnam Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)

18. Western Europe Biologics Market
18.1. Western Europe Biologics Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. COVID Impact
18.1.4. Background Information
18.1.5. Government Initiatives
18.1.6. Regulations
18.1.7. Regulatory Bodies
18.1.8. Major Associations
18.1.9. Taxes Levied
18.1.10. Corporate Tax Structure
18.1.11. Investments
18.1.12. Major Companies
18.2. Western Europe Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.3. Western Europe Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.4. Western Europe Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.5. Western Europe Biologics Market, 2019, by Country, Value ($ Million)
18.6. Western Europe Biologics Market, 2015-2023, Historic and Forecast, by Country
18.7. Western Europe Biologics Market, 2019-2023, Growth and Market Share Comparison, by Country
18.8. Western Europe Biologics Market Metrics
18.8.1. Per Capita Biologics Expenditure, 2019, Western Europe Major Countries
18.8.2. Estimated Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Western Europe Countries
18.8.3. Estimated Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Western Europe Countries
18.9. Western Europe Biologics Market: Country Analysis
18.10. Austria Biologics Market
18.11. Austria Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.12. Austria Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.13. Belgium Biologics Market
18.14. Belgium Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.15. Belgium Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.16. Denmark Biologics Market
18.17. Denmark Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.18. Denmark Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.19. Finland Biologics Market
18.20. Finland Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.21. Finland Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.22. France Biologics Market
18.23. France Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.24. France Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.25. France Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.26. Germany Biologics Market
18.27. Germany Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.28. Germany Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.29. Germany Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.30. Ireland Biologics Market
18.31. Ireland Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.32. Ireland Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.33. Italy Biologics Market
18.34. Italy Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.35. Italy Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.36. Italy Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.37. Netherlands Biologics Market
18.38. Netherlands Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.39. Netherlands Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.40. Norway Biologics Market
18.41. Norway Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.42. Norway Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.43. Portugal Biologics Market
18.44. Portugal Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.45. Portugal Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.46. Spain Biologics Market
18.47. Spain Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.48. Spain Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.49. Spain Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.50. Sweden Biologics Market
18.51. Sweden Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.52. Sweden Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.53. Switzerland Biologics Market
18.54. Switzerland Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.55. Switzerland Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.56. UK Biologics Market
18.57. UK Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
18.58. UK Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
18.59. UK Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Eastern Europe Biologics Market
19.1. Eastern Europe Biologics Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Background Information
19.1.4. Government Initiatives
19.1.5. Regulations
19.1.6. Regulatory Bodies
19.1.7. Major Associations
19.1.8. Taxes Levied
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Eastern Europe Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
19.3. Eastern Europe Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
19.4. Eastern Europe Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.5. Eastern Europe Biologics Market, 2019, by Country, Value ($ Million)
19.6. Eastern Europe Biologics Market, 2015-2023, Historic and Forecast, by Country
19.7. Eastern Europe Biologics Market, 2019-2023, Growth and Market Share Comparison, by Country
19.8. Eastern Europe Biologics Market Metrics
19.8.1. Per Capita Biologics Expenditure, 2019, Eastern Europe Major Countries
19.8.2. Estimated Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Eastern Europe Countries
19.8.3. Estimated Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Eastern Europe Countries
19.9. Eastern Europe Biologics Market: Country Analysis
19.10. Czech Republic Biologics Market
19.11. Czech Republic Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
19.12. Czech Republic Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
19.13. Poland Biologics Market
19.14. Poland Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
19.15. Poland Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
19.16. Romania Biologics Market
19.17. Romania Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
19.18. Romania Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
19.19. Russia Biologics Market
19.20. Russia Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
19.21. Russia Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
19.22. Russia Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

20. North America Biologics Market
20.1. North America Biologics Market Overview
20.1.1. Region Information
20.1.2. Market Information
20.1.3. Impact of COVID-19
20.1.4. Background Information
20.1.5. Government Initiatives
20.1.6. Regulations
20.1.7. Regulatory Bodies
20.1.8. Major Associations
20.1.9. Taxes Levied
20.1.10. Corporate Tax Structure
20.1.11. Investment
20.1.12. Major Companies
20.2. North America Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
20.3. North America Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
20.4. North America Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.5. North America Biologics Market, 2019, by Country, Value ($ Million)
20.6. North America Biologics Market, 2015-2023, Historic and Forecast, by Country
20.7. North America Biologics Market, 2019-2023, Growth and Market Share Comparison, by Country
20.8. North America Biologics Market Metrics
20.8.1. Per Capita Biologics Expenditure, 2019, North America Major Countries
20.8.2. Estimated Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, North America Countries
20.8.3. Estimated Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, North America Countries
20.9. North America Biologics Market: Country Analysis
20.10. Canada Biologics Market
20.11. Canada Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
20.12. Canada Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
20.13. Mexico Biologics Market
20.14. Mexico Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
20.15. Mexico Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
20.16. USA Biologics Market
20.17. USA Biologics Market Overview
20.17.1. Country Information
20.17.2. Market Information
20.17.3. COVID Impact
20.17.4. Background Information
20.17.5. Government Initiatives
20.17.6. Regulations
20.17.7. Regulatory Bodies
20.17.8. Major Associations
20.17.9. Taxes Levied
20.17.10. Corporate Tax Structure
20.17.11. Investment
20.17.12. Major Companies
20.18. USA Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
20.19. USA Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
20.20. USA Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

21. South America Biologics Market
21.1. South America Biologics Market Overview
21.1.1. Region Information
21.1.2. Market Information
21.1.3. COVID Impact
21.1.4. Background Information
21.1.5. Government Initiatives
21.1.6. Regulations
21.1.7. Regulatory Bodies
21.1.8. Major Associations
21.1.9. Taxes Levied
21.1.10. Corporate Tax Structure
21.1.11. Investments
21.1.12. Major Companies
21.2. South America Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
21.3. South America Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
21.4. South America Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.5. South America Biologics Market, 2019, by Country, Value ($ Million)
21.6. South America Biologics Market, 2015-2023, Historic and Forecast, by Country
21.7. South America Biologics Market, 2019-2023, Growth and Market Share Comparison, by Country
21.8. South America Biologics Market Metrics
21.8.1. Per Capita Biologics Expenditure, 2019, South America Major Countries
21.8.2. Estimated Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, South America Countries
21.8.3. Estimated Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, South America Countries
21.9. South America Biologics Market: Country Analysis
21.10. Argentina Biologics Market
21.11. Argentina Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
21.12. Argentina Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
21.13. Brazil Biologics Market
21.14. Brazil Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
21.15. Brazil Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
21.16. Brazil Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.17. Chile Biologics Market
21.18. Chile Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
21.19. Chile Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
21.20. Colombia Biologics Market
21.21. Colombia Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
21.22. Colombia Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
21.23. Peru Biologics Market
21.24. Peru Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
21.25. Peru Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
21.26. Venezuela Biologics Market
21.27. Venezuela Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
21.28. Venezuela Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)

22. Middle East Biologics Market
22.1. Middle East Biologics Market Overview
22.1.1. Region Information
22.1.2. Market Information
22.1.3. Impact of COVID-19
22.1.4. Background Information
22.1.5. Government Initiatives
22.1.6. Regulations
22.1.7. Regulatory Bodies
22.1.8. Major Associations
22.1.9. Taxes Levied
22.1.10. Corporate Tax Structure
22.1.11. Investments
22.1.12. Major Companies
22.2. Middle East Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
22.3. Middle East Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
22.4. Middle East Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.5. Middle East Biologics Market, 2019, by Country, Value ($ Million)
22.6. Middle East Biologics Market, 2015-2023, Historic and Forecast, by Country
22.7. Middle East Biologics Market, 2019-2023, Growth and Market Share Comparison, by Country
22.8. Middle East Biologics Market Metrics
22.8.1. Per Capita Biologics Expenditure, 2019, Middle East Major Countries
22.8.2. Estimated Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Middle East Countries
22.8.3. of the featured countries, Turkey had the lowest average revenue per enterprise in the biologics market with $ 1,681,534. As of 2019, there were 276 biologics enterprises in Turkey. Estimated Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Middle East Countries
22.9. Middle East Biologics Market: Country Analysis
22.10. Israel Biologics Market
22.11. Israel Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
22.12. Israel Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
22.13. Saudi Arabia Biologics Market
22.14. Saudi Arabia Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
22.15. Saudi Arabia Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
22.16. Turkey Biologics Market
22.17. Turkey Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
22.18. Turkey Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
22.19. UAE Biologics Market
22.20. UAE Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
22.21. UAE Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)

23. Africa Biologics Market
23.1. Africa Biologics Market Overview
23.1.1. Region Information
23.1.2. Market Information
23.1.3. Impact of COVID-19
23.1.4. Background Information
23.1.5. Government Initiatives
23.1.6. Regulations
23.1.7. Regulatory Bodies
23.1.8. Major Associations
23.1.9. Taxes Levied
23.1.10. Corporate Tax Structure
23.1.11. Investments
23.1.12. Major Companies
23.2. Africa Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
23.3. Africa Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
23.4. Africa Biologics Market, Segmentation by Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
23.5. Africa Biologics Market, 2019, by Country, Value ($ Million)
23.6. Africa Biologics Market, 2015-2023, Historic and Forecast, by Country
23.7. Africa Biologics Market, 2019-2023, Growth and Market Share Comparison, by Country
23.8. Africa Biologics Market Metrics
23.8.1. Per Capita Biologics Expenditure, 2019, Africa Major Countries
23.8.2. Estimated Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Africa Countries
23.8.3. Estimated Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Africa Countries
23.9. Africa Biologics Market: Country Analysis
23.10. Egypt Biologics Market
23.11. Egypt Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
23.12. Egypt Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
23.13. Nigeria Biologics Market
23.14. Nigeria Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
23.15. Nigeria Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)
23.16. South Africa Biologics Market
23.17. South Africa Biologics Market, Historic Market Growth, 2015-2019, Value ($ Million)
23.18. South Africa Biologics Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value ($ Million)

24. Global Biologics Market Competitive Landscape
24.1. Company Profiles
24.2. Pfizer Inc.
24.2.1. Company Overview
24.2.2. Products and Services
24.2.3. Business Strategy
24.2.4. Financial Overview
24.3. F. Hoffmann-La Roche AG
24.3.1. Company Overview
24.3.2. Products and Services
24.3.3. Business Strategy
24.3.4. Financial Overview
24.4. AbbVie Inc.
24.4.1. Company Overview
24.4.2. Products and Services
24.4.3. Business Strategy
24.4.4. Financial Overview
24.5. Merck & Co., Inc., Inc.
24.5.1. Company Overview
24.5.2. Products and Services
24.5.3. Business Strategy
24.5.4. Financial Overview
24.6. Johnson & Johnson
24.6.1. Company Overview
24.6.2. Products and Services
24.6.3. Business Strategy
24.6.4. Financial Overview

25. Key Mergers and Acquisitions in The Biologics Market
25.1. Abbvie Acquired Allergan
25.2. WuXi Biologics Acquired Drug Product Manufacturing Plant From Bayer
25.3. Takeda Pharmaceutical Company Acquired PvP Biologics, Inc.
25.4. True North Acquired Stake in Biocon Biologics
25.5. Catalent, Inc. Acquired Bristol Myers Squibb’s Oral Dose Manufacturing Facility
25.6. Bristol Myers Acquired Celgene
25.7. Evotec Acquired Just Biotherapeutics
25.8. AstraZeneca Strikes Stock Deal With Daiichi Sankyo
25.9. Boehringer Acquires Rights To ICD Therapeutics and Its Biologics-Delivery Platform
25.10. Catalent, Inc. Acquired Cook Pharmica LLC
25.11. ADMA Biologics Acquired Biotest’s Therapy Business
25.12. Eagle Pharmaceuticals Acquired Arsia Therapeutics
25.13. Takeda Acquired Baxalta’s Manufacturing Facility

26. Market Background: Pharmaceuticals Market
26.1. Pharmaceuticals Market Characteristics
26.1.1. Market Definition
26.1.2. Segmentation by Type
26.2. Global Pharmaceuticals Market, Segmentation by Type, 2015-2023, Value ($ Billion)
26.3. Global Pharmaceuticals Market, 2019, by Region, Value ($ Billion)
26.4. Global Pharmaceuticals Market, 2015-2023, Historic and Forecast, by Region

27. Biologics Market Opportunities and Strategies
27.1. Global Biologics Market in 2023 - Countries Offering Most New Opportunities
27.2. Global Biologics Market in 2023 - Segments Offering Most New Opportunities
27.3. Global Biologics Market in 2023 - Growth Strategies
27.3.1. Market Trend Based Strategies
27.3.2. Competitor Strategies

28. Biologics Market, Conclusions and Recommendations
28.1. Conclusions
28.2. Recommendations
28.2.1. Product
28.2.2. Place
28.2.3. Price
28.2.4. Promotion
28.2.5. People

29. Appendix
29.1. Market Data Sources
29.2. Research Methodology
29.3. Currencies
29.4. Research Inquiries
29.5. About the Publisher
29.6. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
This report describes and evaluates the global biologics market. It covers 2015 to 2019, termed the historic period, and 2019 to 2023 termed the forecast period, along with further forecasts for the periods 2023-2025 and 2025-2030. The biologics market consists of sales of biologics and related services by entities that produce biologics or biosimilars to treat and prevent various microbial diseases and cancers.

The global biologics market reached a value of nearly $269,152.8 million in 2019, having increased at a compound annual growth rate (CAGR) of 12.6% since 2015. The market is expected to decline from $269,152.8 million in 2019 to $239,168.6 million in 2020 at a rate of -11.1%. The decline is mainly due to lockdown and social distancing norms imposed by various countries and economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 14.7% from 2021 and reach $464,604.9 million in 2023. The market is expected to reach $610,253.2 million in 2025, and $1,234,925.6 million in 2030.

Growth in the historic period resulted from aging population, government initiatives, ability to command high prices, and increased need for immunology. Factors that negatively affected growth in the historic period were pricing pressures from regulators, and lack of awareness on biosimilars among primary care physicians and specialists. Going forward, increase in funding, technological advances, increase in healthcare access, robust research and development activities for development of oral biologics, and lean towards pills over injections will drive the growth. Factors that could hinder the growth of the biologics market in the future include high stringency and low turnover for clinical trials, stringent regulations related to biosimilar approvals, prolonged production and approval time, and nomenclature challenges.

The biologics market is segmented by type into monoclonal antibodies, therapeutic proteins, and vaccines. The monoclonal antibodies market was the largest segment of the biologics market segmented by type, accounting for 42.6% of the total in 2019. Going forward, the therapeutic proteins segment is expected to be the fastest growing segment in the biologics market segmented by type, at a CAGR of 14.9% during 2019-2023.

The monoclonal antibodies (MAbS) market is further segmented by type into anti-cancer MAbS, immunological MAbS, anti-infective MAbS, neuropharmacological MAbS, cardiovascular and cerebrovascular MAbS, and other MAbS. The anti-cancer MAbS market was the largest segment of the monoclonal antibodies market segmented by type, accounting for 50.5% of the total in 2019. It is also expected to be the fastest growing segment in the monoclonal antibodies market segmented by type, at a CAGR of 15.3% during 2019-2023.

The therapeutic proteins market is further segmented by type into metabolic disorders therapeutic proteins, cancer therapeutic proteins, cardiovascular therapeutic proteins, immunological therapeutic proteins, and others-therapeutic proteins. The metabolic disorders therapeutic proteins market was the largest segment of the therapeutic proteins market segmented by type, accounting for 35.4% of the total in 2019. It is also expected to be the fastest growing segment in the therapeutic proteins market segmented by type, at a CAGR of 15.5% during 2019-2023.

The vaccines market is further segmented by type into anti-infective vaccines, autoimmunity vaccines, and others-vaccines. The anti-infective vaccines market was the largest segment of the vaccines market segmented by type, accounting for 43.6% of the total in 2019. It is also expected to be the fastest growing segment in the vaccines market segmented by type, at a CAGR of 14.4% during 2019-2023.

The biologics market is also segmented by distribution channel into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies market was the largest segment of the biologics market segmented by distribution channel, accounting for 50.3% of the total in 2019. Going forward, the online pharmacies segment is expected to be the fastest growing segment in the biologics market segmented by distribution channel, at a CAGR of 21.1% during 2019-2023.

The biologics market is also segmented by route of administration into oral, and others. The others market was the largest segment of the biologics market segmented by route of administration, accounting for 98.9% of the total in 2019. Going forward, the oral segment is expected to be the fastest growing segment in the biologics market segmented by route of administration, at a CAGR of 17.1% during 2019-2023.

The biologics market is segmented by also drug classification into branded drugs, and generic drugs. The branded drugs market was the largest segment of the biologics market segmented by drug classification, accounting for 80.2% of the total in 2019. Going forward, the generic drugs segment is expected to be the fastest growing segment in the biologics market segmented by drug classification, at a CAGR of 15.5% during 2019-2023.

The biologics market is also segmented by mode of purchase into prescription drugs, and OTC drugs. The prescription drugs market was the largest segment of the biologics market segmented by mode of purchase, accounting for 78.1% of the total in 2019. Going forward, the OTC drugs segment is expected to be the fastest growing segment in the biologics market segmented by mode of purchase, at a CAGR of 14.8% during 2019-2023.

Asia Pacific was the largest region in the global biologics market, accounting for 53.1% of the total in 2019. It was followed by Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the biologics market will be Asia Pacific, and Africa, where growth will be at CAGRs of 19.7% and 17.9% respectively. These will be followed by South America, and the Middle East, where the markets are expected to grow at CAGRs of 16.5% and 15.0% respectively.

The biologics market is highly concentrated, with a small number of large players. The top ten competitors in the market made up to 67.4% of the total market in 2019. Major players in the market include Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Merck & Co., Inc., Johnson & Johnson and others

The top opportunities in the biologics market segmented by type will arise in the monoclonal antibodies segment, which will gain $83,966.0 million of global annual sales by 2023. The top opportunities in the biologics market segmented by distribution channel will arise in the hospital pharmacies segment, which will gain $95,544.3 million of global annual sales by 2023. The top opportunities in the biologics market segmented by route of administration will arise in the others segment, which will gain $192,740.4 million of global annual sales by 2023. The top opportunities in the biologics market segmented by drug classification will arise in the branded drugs segment, which will gain $153,717.8 million of global annual sales by 2023. The top opportunities in the biologics market segmented by mode of purchase will arise in the prescription drugs segment, which will gain $152,134.2 million of global annual sales by 2023.The biologics market size will gain the most in the USA at $88,049.4 million.

Market-trend-based strategies for the biologics market include leveraging revised and less stringent regulations to develop new and improved biologics, shifting to biologic drug development to capitalize on the growing demand for these drugs, investing in R&D for the development of innovative biologics, and investing in research and development of biologics for the treatment of complex diseases. Player-adopted strategies in the biologics market include expanding through establishment of manufacturing and R&D facilities, expanding through new biologic launches for specific diseases and sustainable investments, expanding through acquisition of biotechnology companies, and expanding through strategic collaborations & agreements with industry leaders.

Amidst the unprecedented outbreak of corona virus, governments across the world are advising people to stay indoors and practice social distancing, to reduce the spread of the pandemic. This has affected the biologics industry. As global supply of raw materials and equipment was affected due to containment measures, biologics manufacturers faced additional challenges. Research and development and manufacturing activities in the pharmaceutical industry are also experiencing challenges and will continue to face repercussions of the outbreak in the long term. The demand for biologics is anticipated to grow at a rapid pace due to the novel coronavirus outbreak. The pharmaceutical companies across the world are investing in research and development of vaccines against COVID-19, is positively affecting the biologics market.

To take advantage of the opportunities, the publisher recommends the biologics companies to focus on research & development, use of large molecules, focus on drug development for complex diseases, expand in emerging markets, set up authorized distributors and sales representatives, leverage online pharmacies, targeting local pharmacies to spread awareness, provide competitively priced offerings in low-income countries to reach new users, skimmed pricing for innovative drugs, direct-to-customer (DTC) advertising, participate in trade shows and events, increased requirement of R&D scientists.
Note: Product cover images may vary from those shown
  • Pfizer Inc.
  • F. Hoffmann-La Roche AG
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll